Professor Lane and his group are currently focused on understanding:
The regulation of OX40-ligand on LTi, as switching off expression (as in the embryo) would be a very effective way to suppress CD4-mediated diseases How human LTi might be modified in disease to cause secondary CD4 immunodeficiency.
19972022
Research activity per year
Fingerprint
Dive into the research topics where Peter Lane is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
